Comments
Loading...
Kiromic BioPharma Analyst Ratings and Price Targets | OTC:KRBPQ | Benzinga
Kiromic BioPharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kiromic BioPharma Corp from these most-recent analyst ratings.
Analyst Ratings for Kiromic BioPharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Kiromic BioPharma (KRBPQ) stock?
There is no price target for Kiromic BioPharma
What is the most recent analyst rating for Kiromic BioPharma (KRBPQ)?
There is no analyst for Kiromic BioPharma
When was the last upgrade for Kiromic BioPharma (KRBPQ)?
There is no last upgrade for Kiromic BioPharma
When was the last downgrade for Kiromic BioPharma (KRBPQ)?
There is no last downgrade for Kiromic BioPharma.
When is the next analyst rating going to be posted or updated for Kiromic BioPharma (KRBPQ)?
There is no next analyst rating for Kiromic BioPharma.
Is the Analyst Rating Kiromic BioPharma (KRBPQ) correct?
There is no next analyst rating for Kiromic BioPharma.
Browse analyst ratings and price targets on all stocks.